CASP3 and prostate cancer: Additionally, treatment with miR-146a inhibitors significantly prevented 5-Aza-CdR-induced caspase-3 activation in both cell lines (Figure 1C), indicating that miR-146a played an important role in 5-Aza-CdR-induced cell death in prostate cancer cells, regardless of androgen dependency.